This paper presents updated guidelines for standardized cardiovascular magnetic resonance (CMR) imaging protocols, covering various aspects from patient preparation and safety considerations to specific disease-oriented protocols. It emphasizes the use of advanced imaging techniques like T1 and T2 mapping, as well as stress perfusion and late gadolinium enhancement, while acknowledging the limitations posed by vendor-specific sequences and resource availability.

Several authors disclose relationships with pharmaceutical and imaging companies, including research grants, lecture fees, and institutional research support from Siemens Healthineers, Philips Healthcare, Bayer, and Amgen. These relationships could potentially influence the recommendations made in the guidelines.

This paper provides a valuable update to standardized CMR protocols, reflecting advancements in the field. While it lacks original research findings, its comprehensive nature and clinical relevance make it a useful resource for practitioners. However, the limitations related to resource dependence and vendor specificity restrict its broader applicability and impact, justifying a rating of 3.